{"name":"Insilico Medicine","slug":"insilico","ticker":"Private","exchange":"Private","domain":"insilico.com","description":"Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery.","hq":"Hong Kong / Shanghai, China","founded":0,"employees":"","ceo":"Alex Zhavoronkov","sector":"AI Drug Discovery","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1B (est. private valuation)","metrics":{"revenue":80000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ISM5411 tablets","genericName":"ISM5411 tablets","slug":"ism5411-tablets","indication":"Other","status":"phase_2"},{"name":"ISM5939","genericName":"ISM5939","slug":"ism5939","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ISM5411 tablets","genericName":"ISM5411 tablets","slug":"ism5411-tablets","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ISM5939","genericName":"ISM5939","slug":"ism5939","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2022-02-22","type":"deal","headline":"Insilico Medicine Partners with Novartis to Develop AI-Driven Therapies","summary":"Insilico Medicine partnered with Novartis to develop AI-driven therapies for various diseases, including cancer and cardiovascular diseases.","drugName":"","sentiment":"positive"},{"date":"2021-10-25","type":"regulatory","headline":"Insilico Medicine Receives FDA Clearance for Its AI-Powered Clinical Trial Design Tool","summary":"Insilico Medicine received FDA clearance for its AI-powered clinical trial design tool, which aims to improve the efficiency and effectiveness of clinical trials.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONVV5UlpjckdOTUlnR1hsU3BVTzEyQVlsN2dvNWstOHlBZzVIU3ZEVjhHQkk1RTB2RlZfSHJZZnV1QWV2X293aUZYS3FYYjl1V1c0dlQxSF91blJuU1hpUTJHUWxiX05PVXE1YVlUWmdPX2VTRnpsR2o4UlFuTHdDWHMxVDY3SllzWlZPVVc0VkU1TlloQnNyd0VuM1AyX3RVOHRiOGJvWVJjX1JsNTVHZ3g5M0NXMDVvN2N4MjBEZGZmbEpi?oc=5","date":"2026-04-08","type":"pipeline","source":"TipRanks","summary":"Insilico Medicine Highlights AI Platform Capabilities Ahead of Pharma.AI Event - TipRanks","headline":"Insilico Medicine Highlights AI Platform Capabilities Ahead of Pharma.AI Event","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPYy1Ha3dmMmdlS3ZYbUF5U2xfUVo5b1hLbnJMMW40Qk8wck5JNGRZUWZnMzRNZmJZSUxxME5kczh5aWtmMnlpOVRmVTRMQjdNZGVSeVlZRkhOX3ZLYkRGNUdGMmxGczRGbDE2OGJlWkdQamhYeW0xbkRDNG5DaXh4WHVDNEVvZkhMd1FSUkYwVjUxVjJUcWxsWjU4Q1ZHdG1JLVpPbDdaU0NuLUgxSWVTZFRNSlNQd3JKanFaMjlVOTdKYzNOYnc?oc=5","date":"2026-04-07","type":"pipeline","source":"TipRanks","summary":"Insilico Medicine Showcases AI Drug Discovery Platform Ahead of Pharma.AI Event - TipRanks","headline":"Insilico Medicine Showcases AI Drug Discovery Platform Ahead of Pharma.AI Event","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPaXlLVTlYMkJ0MW5YR21zblFvQzNNY2ZsYUh4dnBRY1dsNGlCeldwM1BhaE1DMTNWTF9IWDZsTmZWMlI0WDBfeFlYbjRTaWJWUy0ydVRoU1NXZTFfV0Z2eFNmdm03SDJOUE5CQVh5Q1JwckdiUjNLYk9jT0FaSGtzME1mNA?oc=5","date":"2026-03-08","type":"deal","source":"Insilico Medicine","summary":"Liquid AI and Insilico Medicine Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for Drug Discovery - Insilico Medicine","headline":"Liquid AI and Insilico Medicine Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNWVpvSENCLXNEbzFXRVpjbjBkMUlsWV9jeUw4SDF4OGN3TEhrT2xvV3ItOXQ1OXJTd1FfVDRPWkFiLVpKX3ctVnNYUkNVQ1BIWjZ3eGJMZzVYbVNHRTQ1dGZValZqOWNGVUJjQ2tvb3NlMjZDWXU2cGgxRWw5Zml1QjVvNzM0Zno1WmtBYTduOGZaNHNROFlZS3dIekdnd0ZpTWoweVpaUFlqcFFVNEpKeVU2SHZMcHBsTmhwcENfNUF4NjRiNnp4b0FyMnI3NDcyQm5rVWNHc0ptd0dX?oc=5","date":"2026-03-05","type":"pipeline","source":"BioPharma APAC","summary":"Insilico Medicine And Liquid AI Introduce Lightweight Foundation Model For End To End Drug Discovery - BioPharma APAC","headline":"Insilico Medicine And Liquid AI Introduce Lightweight Foundation Model For End To End Drug Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNdjZIN09ubFNYcm8yX25SZGo4dHJweDc3VC1YaFFPeVJKMUZFTU1fNHMwbmpSV0dOVDdIcVYyS1FnUVRfYkdNVTdUVEZnc0RibnlTNEs5ZkJuM0hXVms5OXpBYzNWM1B6YjAyamRGZXdvN1NySjhHdkpGY0JobngwZGt6RTdQb2EzSU9JUlZ2a2l2Q1hSQ0hzWjZmdlFiTjEwUDlSYmx6WQ?oc=5","date":"2026-03-05","type":"pipeline","source":"Drug Target Review","summary":"New AI foundation model aims to speed up drug discovery - Drug Target Review","headline":"New AI foundation model aims to speed up drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1pZmxkbzJiRUhBMEVWYnNGWHpjZmd4MFlqSnNRV2J3ZmFheHBLbE9lYVhDYUQyN3lHS3BWRVZ5VU1aLVJZSEdLbi1WNFh4c0R4aDRGRDNsejdkZWFFLUdYbnVlN2ZXcktzSnhTczV4Uk5oWEtpQ3c?oc=5","date":"2025-12-31","type":"pipeline","source":"pharmaphorum","summary":"Insilico ends 2025 with $293m Hong Kong IPO - pharmaphorum","headline":"Insilico ends 2025 with $293m Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQNzNLWk1oa01GajBkTkFMdHpRRWtSaE5MN0RpYUJiYnB3cEFnX3ljdlpnSl9UQVJ1blpNY0g2ZzQwUUtVUlo4U1JGZDBBQjhVd05GeXVWaFd6cHE4SFhNRWxVcHdrOWpXVlRrcUlOQ3NnZTR3MDN1VDJpNFJuTEdxUTNwOA?oc=5","date":"2025-12-19","type":"earnings","source":"Insilico Medicine","summary":"Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence - Insilico Medicine","headline":"Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE91bDFrbjBVMXhEZ2ZzRFlJQVF1VlU1YXdOMk5RRDZfREwxd3hwNzljSEc5Vm42WkZadk5kNVhqZm1lTldUbnRCRExVSDVBQnNCN1RPcFRVUTFja1ht?oc=5","date":"2025-12-08","type":"pipeline","source":"EurekAlert!","summary":"Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence - EurekAlert!","headline":"Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence - Eurek","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPX0tKU0hvVkt2dHp6N1g3VlZma2xrYV9ucmg4Z1NlNE1kRXFMcjBmU21LUW0xRVYzMkJEVFVzNHd5cUFXb2ZwZnVJTzJNQ2Jrbzcta3BrZ25tNlhSYldqd3F3RnlCbnFDRGpreWc5eFpGRTlxWk5kNDVyVjA5Q3Q0WF9pSWRudDdnUkVEeldtNUtTVldhd2FMVTFCYURpcXN5?oc=5","date":"2025-10-22","type":"pipeline","source":"Pharma Voice","summary":"AI giants Nvidia, Microsoft and Google are making critical moves in pharma R&D - Pharma Voice","headline":"AI giants Nvidia, Microsoft and Google are making critical moves in pharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1UaVlqc01aaHplRTRUVk5SV3lqTkZha0hpSU5IU0xmT0JQZmtxaV85MV9aZVZ0QW4yTWVWZzhoOFk3czh5QjdHN0F1eFBlZHFJaXNBV1QtSlhIUW41?oc=5","date":"2025-07-07","type":"pipeline","source":"EurekAlert!","summary":"Pharma.ai summer 2025 updates: Join Insilico Medicine on July 10 for the future of AI-empowered medical research boost - EurekAlert!","headline":"Pharma.ai summer 2025 updates: Join Insilico Medicine on July 10 for the future of AI-empowered medical research boost -","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-09","type":"pipeline","source":"Business Wire","summary":"Artificial Intelligence in Drug Discovery Market Research Report 2025-2030 Featuring Leading Players - Atomwise, AWS, BenevolentAI, Google, IBM, Insilico Medicine, Microsoft, NVIDIA, Recursion Pharma ","headline":"Artificial Intelligence in Drug Discovery Market Research Report 2025-2030 Featuring Leading Players - Atomwise, AWS, Be","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNcW14aWNlUC04ZGpLOGdoNHUxZ0hKSnRPeE9yb0xTY2xpZWE0aFpsdi1yUXlkUmZCSXZ4Sjg2N2RNTTZqc09RUG82RFlTZzdMQjk0Z3FNM1UyQV9UWkxROHNTdzZhNll0emJMa1k0a2lCTmg3LTN5SXZkT201VUJFZHRFWk16ZFFReE1SYnZYY2w4LU9DTUE?oc=5","date":"2025-03-13","type":"pipeline","source":"MobiHealthNews","summary":"Insilico Medicine scores $110M for AI-enabled drug discovery - MobiHealthNews","headline":"Insilico Medicine scores $110M for AI-enabled drug discovery","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["DeepMind","Recursion Pharmaceuticals","Illumina"],"therapeuticFocus":["Cancer","Cardiovascular Diseases"],"financials":null,"yahoo":null}